Advances in Radionuclide-Labeled Biological Carriers for Tumor Imaging and Treatment
Yaozhang Yang,
No information about this author
Jing Wang,
No information about this author
Yan Zhong
No information about this author
et al.
ACS Applied Materials & Interfaces,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Biological
carriers
have
emerged
as
significant
tools
to
deliver
radionuclides
in
nuclear
medicine,
providing
a
meaningful
perspective
for
tumor
imaging
and
treatment.
Various
radionuclide-labeled
biological
been
developed
meet
the
needs
of
biomedical
applications.
This
review
introduces
principles
radionuclide-mediated
therapy
selected
criteria
them,
well
comprehensive
description
characteristics
functions
representative
including
bacteria,
cells,
viruses,
their
derivatives,
emphasizing
labeled
strategies
combined
with
radionuclides.
Subsequently,
we
in-depth
introduce
application
treatment,
behaviors
vivo
metastasis
treatment
by
radionuclide
therapy,
plus
other
radiation-induced
photodynamic
therapy.
Finally,
challenges
prospects
are
discussed
improve
shortcomings
this
innovative
platform
promote
clinical
transformation
field
medical
imaging.
Language: Английский
Tumor-stromal opening via S. typhimurium VNP20009 administration for complete inhibition of refractory tumor growth with liposomal anticancer drugs
Akari Kato,
No information about this author
Shoko Nomura,
No information about this author
Maiko Takahashi
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Language: Английский
Stealth Missiles with Precision Guidance: A Novel Multifunctional Nano-Drug Delivery System Based on Biomimetic Cell Membrane Coating Technology
Yuyan Zhou,
No information about this author
Xinyue Wang,
No information about this author
Xiaorong Tian
No information about this author
et al.
Materials Today Bio,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101922 - 101922
Published: May 1, 2025
Language: Английский
The Role of Bacteria in Central Nervous System Tumors: Opportunities and Challenges
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(6), P. 1053 - 1053
Published: May 23, 2024
Tumors
of
the
central
nervous
system
(CNS)
are
severe
and
refractory
diseases
with
poor
prognosis,
especially
for
patients
malignant
glioblastoma
brain
metastases.
Currently,
numerous
studies
have
explored
potential
role
bacteria
intestinal
flora
in
tumor
development
treatment.
Bacteria
can
penetrate
blood-brain
barrier
(BBB),
targeting
hypoxic
microenvironment
at
core
tumors,
thereby
eliminating
tumors
activating
both
innate
adaptive
immune
responses,
rendering
them
promising
therapeutic
agents
CNS
tumors.
In
addition,
engineered
derivatives,
such
as
bacterial
membrane
proteins
spores,
also
be
used
good
candidate
carriers
targeted
drug
delivery.
Moreover,
regulate
metabolism
influence
through
"gut-brain
axis".
Therefore,
anti-tumor
therapy,
delivery,
intervention
provide
modalities
treatment
this
paper,
we
performed
a
comprehensive
review
mechanisms
practices
therapy
discussed
future
research
directions
field.
Language: Английский
Harnessing and Mimicking Bacterial Features to Combat Cancer: From Living Entities to Artificial Mimicking Systems
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(35)
Published: Aug. 1, 2024
Bacterial-derived
micro-/nanomedicine
has
garnered
considerable
attention
in
anticancer
therapy,
owing
to
the
unique
natural
features
of
bacteria,
including
specific
targeting
ability,
immunogenic
benefits,
physicochemical
modifiability,
and
biotechnological
editability.
Besides,
bacterial
components
have
also
been
explored
as
promising
drug
delivery
vehicles.
Harnessing
these
features,
cutting-edge
biotechnologies
applied
attenuated
tumor-targeting
bacteria
with
properties
or
functions
for
potent
effective
cancer
treatment,
strategies
gene-editing
genetic
circuits.
Further,
advent
bacteria-inspired
micro-/nanorobots
mimicking
artificial
systems
furnished
fresh
perspectives
formulating
developing
highly
efficient
systems.
Focusing
on
advantages
this
review
delves
into
advances
bacteria-derived
treatment
recent
years,
which
experienced
a
process
from
living
entities
Meanwhile,
summary
relative
clinical
trials
is
provided
primary
challenges
impeding
their
application
are
discussed.
Furthermore,
future
directions
suggested
combat
cancer.
Language: Английский
Bacteria-Based Bioactive Materials for Tumor Immunotherapy
Yongcan Li,
No information about this author
Fangfang Cao,
No information about this author
Lie Ma
No information about this author
et al.
Precision medicine and engineering.,
Journal Year:
2024,
Volume and Issue:
unknown, P. 100013 - 100013
Published: Nov. 1, 2024
Language: Английский
Recent Advances in Bacterial Outer Membrane Vesicles: Effects on the Immune System, Mechanisms and their Usage for Tumor Treatment
Journal of Pharmaceutical Analysis,
Journal Year:
2024,
Volume and Issue:
14(12), P. 101049 - 101049
Published: July 23, 2024
Tumor
treatment
remains
a
significant
medical
challenge,
with
many
traditional
therapies
causing
notable
side
effects.
Recent
research
has
led
to
the
development
of
immunotherapy,
which
offers
numerous
advantages.
Bacteria
inherently
possess
motility,
allowing
them
preferentially
colonize
tumors
and
modulate
tumor
immune
microenvironment,
thus
influencing
efficacy
immunotherapy.
Bacterial
outer
membrane
vesicles
(OMVs)
secreted
by
gram-negative
bacteria
are
nanoscale
lipid
bilayer
structures
rich
in
bacterial
antigens,
pathogen-associated
molecular
patterns
(PAMPs),
various
proteins,
vesicle
structures.
These
features
allow
OMVs
stimulate
system
activation,
generate
responses,
serve
as
efficient
drug
delivery
vehicles.
This
dual
capability
enhances
effectiveness
immunotherapy
combined
chemotherapy
or
phototherapy,
thereby
improving
anticancer
efficacy.
Current
concentrated
on
engineering
enhance
production
yield,
minimize
cytotoxicity,
improve
safety
treatments.
Consequently,
hold
great
promise
for
applications
vaccine
development,
delivery.
article
provides
an
overview
structural
composition
mechanisms
OMVs,
details
modification
strategies,
reviews
progress
using
their
anti-tumor
mechanisms.
Additionally,
it
discusses
challenges
faced
translating
OMV-based
into
clinical
practice,
aiming
provide
comprehensive
understanding
OMVs'
potential
in-depth
application.
Language: Английский
Bioinspired micro‐ and nanostructured systems for cancer therapy
Ruizhen Yang,
No information about this author
Bing Zhang,
No information about this author
Xiawei Fei
No information about this author
et al.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(12)
Published: Nov. 28, 2024
Abstract
Numerous
organisms
in
nature
have
demonstrated
enhanced
biocompatibility,
precise
tumor
targeting
capabilities,
and
efficient
tissue
traversal
within
the
human
body.
Drawing
inspiration
from
these
organisms,
researchers
employed
bioengineering,
bioconjugation,
micro‐
or
nanotechnology
to
fabricate
bioinspired
nanostructured
systems.
These
systems
play
a
crucial
role
addressing
limitations
of
conventional
anticancer
drugs
nanomaterials
concerning
effective
penetration
physiological
barriers,
as
well
selective
targeting,
thereby
leading
improved
therapeutic
efficacy
while
minimizing
nonspecific
adverse
effects
on
healthy
cells.
Consequently,
extensive
exploration
has
been
undertaken
across
various
cancer
treatment
modalities
with
some
progressing
into
preclinical
clinical
stages.
However,
our
understanding
this
field
remains
limited
which
may
impede
research
progress,
translation
efforts,
practical
applications.
Therefore,
study
presents
systematic
classification
for
therapy
that
comprehensively
elucidates
their
sources
design
principles.
Furthermore,
it
extensively
discusses
current
status
efforts
identifying
prevailing
challenges
exploring
future
prospects.
This
work
will
establish
robust
theoretical
framework
serve
valuable
reference
facilitate
advancements
application
field.
Language: Английский